These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27521796)
1. Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation. Huang D; Wang S; Wang A; Chen X; Zhang H Acta Biochim Biophys Sin (Shanghai); 2016 Sep; 48(9):788-94. PubMed ID: 27521796 [TBL] [Abstract][Full Text] [Related]
2. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway. Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167 [TBL] [Abstract][Full Text] [Related]
4. Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. Ma J; Wu K; Liu K; Miao R Cancer Biomark; 2018; 22(1):63-72. PubMed ID: 29439314 [TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of CB2 in the progression of non-small-cell lung cancer. Xu S; Ma H; Bo Y; Shao M Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective. Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014 [TBL] [Abstract][Full Text] [Related]
8. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701 [TBL] [Abstract][Full Text] [Related]
9. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo. Xie M; He CS; Wei SH; Zhang L Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913 [TBL] [Abstract][Full Text] [Related]
10. ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer. Lv X; Li Y; Qian M; Ma C; Jing H; Wen Z; Qian D Mol Med Rep; 2014 May; 9(5):1935-40. PubMed ID: 24626788 [TBL] [Abstract][Full Text] [Related]
11. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
12. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway. Piao Z; Hong CS; Jung MR; Choi C; Park YK Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472 [TBL] [Abstract][Full Text] [Related]
13. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway. Yu SH; Zhang CL; Dong FS; Zhang YM J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230 [TBL] [Abstract][Full Text] [Related]
14. TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Finger EC; Turley RS; Dong M; How T; Fields TA; Blobe GC Carcinogenesis; 2008 Mar; 29(3):528-35. PubMed ID: 18174241 [TBL] [Abstract][Full Text] [Related]
15. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Ding XY; Ding J; Wu K; Wen W; Liu C; Yan HX; Chen C; Wang S; Tang H; Gao CK; Guo LN; Cao D; Li Z; Feng GS; Wang HY; Xu ZF Oncogene; 2012 Jun; 31(23):2899-906. PubMed ID: 22002304 [TBL] [Abstract][Full Text] [Related]
16. Thymosin β4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma. Hong KO; Lee JI; Hong SP; Hong SD Amino Acids; 2016 Jan; 48(1):117-27. PubMed ID: 26276576 [TBL] [Abstract][Full Text] [Related]
17. Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway. Kong R; Feng J; Ma Y; Zhou B; Li S; Zhang W; Jiang J; Zhang J; Qiao Z; Zhang T; Zang Q; He X Oncol Rep; 2016 Apr; 35(4):2306-14. PubMed ID: 26782286 [TBL] [Abstract][Full Text] [Related]
18. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Shen L; Yang M; Lin Q; Zhang Z; Zhu B; Miao C Oncol Rep; 2016 Aug; 36(2):877-85. PubMed ID: 27373316 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of TrxR2 suppressed NSCLC cell proliferation, metabolism and induced cell apoptosis through decreasing antioxidant activity. Bu L; Li W; Ming Z; Shi J; Fang P; Yang S Life Sci; 2017 Jun; 178():35-41. PubMed ID: 28414076 [TBL] [Abstract][Full Text] [Related]
20. Overexpression and biological function of TMEM48 in non-small cell lung carcinoma. Qiao W; Han Y; Jin W; Tian M; Chen P; Min J; Hu H; Xu B; Zhu W; Xiong L; Lin Q Tumour Biol; 2016 Feb; 37(2):2575-86. PubMed ID: 26392108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]